A comprehensive ecosystem of digital health platforms emerged on July 14, 2026, demonstrating the healthcare industry's commitment to care coordination and remote patient management. Leading companies including VeeOne Health, PatientIQ, ChronicCareIQ, and Cadence Solutions have introduced sophisticated virtual care delivery systems enabling proactive patient management and remote monitoring across multiple conditions. Specialized platforms address distinct clinical needs: Babyscripts supports pregnancy and postpartum care, Rula connects patients with behavioral health providers, Brightside Health delivers comprehensive mental health management, while Force Therapeutics and SeamlessMD guide patients through surgical journeys with personalized education and recovery tracking. Condition-specific solutions like Tidepool for diabetes management and Medbridge for rehabilitation demonstrate targeted approaches to chronic disease management. NeuroFlow integrates behavioral health screening into clinical workflows, and CoachCare emphasizes engagement outcomes. These platforms collectively capture patient-reported outcomes, enable longitudinal monitoring, and support self-management across the care continuum, reflecting a significant shift toward technology-enabled coordination that connects patients and care teams while improving outcomes and engagement through scalable, personalized interventions.

Healthcare delivery is shifting from episodic office visits to continuous care models that support patients daily, particularly as chronic disease drives healthcare utilization and costs. Brook provides the infrastructure enabling organizations to deliver longitudinal, continuous care at scale through remote monitoring, AI-powered clinical intelligence, coordinated workflows, and human care teams. This approach identifies clinical risks earlier, improves patient engagement, and enables timely interventions before conditions deteriorate. Continuous care encompasses ongoing patient engagement, remote health data monitoring, medication support, personalized education, AI-driven clinical prioritization, care coordination, and proactive intervention between visits. Since over 90 percent of healthcare spending relates to chronic disease and mental health conditions, and most health outcomes depend on factors outside clinical settings, the traditional episodic model creates dangerous gaps. Patients managing complex care largely independently often experience poor medication adherence, disease progression, preventable emergency visits, and hospital readmissions, while clinicians face burnout. By maintaining ongoing connections with patients throughout their healthcare journey, continuous care closes these gaps, improving clinical outcomes, reducing avoidable utilization, and supporting financially sustainable care delivery models.

This qualitative study examines the complex systems and policy barriers faced by homeless adults with intellectual and developmental disabilities (IDD). Researchers interviewed eighteen service professionals—including clinicians, case managers, allied professionals, and outreach specialists—between March and June 2021 to understand how individuals with IDD navigate multiple public systems to access care. The analysis identified five distinct systems with which this population frequently interacts and revealed two critical themes: structurally fragmented care for complex needs and policy-driven gaps in care. The findings demonstrate that homeless adults with IDD experience perpetual cycling through fragmented public systems, creating barriers to essential services and care coordination. The research underscores how structural ableism embedded throughout existing systems prevents health equity. The study advocates for transitioning from crisis-driven care models to cohesive care ecosystems and emphasizes the urgent need for integrated approaches that reduce system churn. These insights are particularly significant given the housing affordability crisis has disproportionately increased homelessness among adults with IDD, making coordinated, equity-focused service delivery models essential for this vulnerable population.

Social determinants of health—including economic stability, education, healthcare access, housing, and social support—significantly influence eating disorder risk, diagnosis, and recovery outcomes, accounting for approximately 30 to 55 percent of overall health outcomes. A continuing education webinar featuring Nicole Christian-Brathwaite, MD, National Medical Director of Child and Adolescent Psychiatry at Monte Nido, and Erikka Taylor, MD, MPH, DFAACAP, Chair of Project HEAL's Board of Directors, addressed how clinicians can provide more equitable eating disorder care. Although eating disorders affect individuals across all demographics, recognition and treatment remain unequally distributed across populations due to persistent clinical stereotypes about who develops these conditions. Food insecurity, discrimination, poverty, unstable housing, and limited healthcare access correlate with increased eating disorder risk and delayed diagnosis. The webinar emphasized that early recognition remains one of the strongest predictors of improved outcomes, underscoring the critical importance of addressing social determinants to ensure equitable access to timely treatment for all populations vulnerable to eating disorders.

For most of modern medical history, microbes were viewed primarily as threats. Bacteria, viruses, and fungi were ‘problems’ physicians were trying to eliminate with disinfectants and antibiotics. However, over the past two decades a major scientific shift has occurred. Researchers now recognise that trillions of micro-organisms living in and on the human body, collectively called the microbiome, play an essential role in health.

With rapid advances in synthetic biology and genetic engineering, genetically engineered bacteria (GEB) have emerged as a promising platform for biological therapy, addressing key limitations of conventional drug delivery systems and demonstrating significant clinical potential. By leveraging a modular design framework, GEB exhibits high biocompatibility and programmability, enabling precise genetic modifications for targeted delivery, dynamic responsiveness, and sustained therapeutic effects. This review systematically examines the therapeutic development of GEB, focusing on its pivotal roles in tumor therapy, inflammatory bowel disease (IBD), metabolic disorders, and the treatment of complex infections. It outlines key design strategies—including sensing, payload release, and biocontainment modules—as well as evaluation frameworks and mechanisms of action.

Although probiotic-based bionic strategies show therapeutic promise for inflammatory bowel disease, their clinical translation is limited by poor gastric acid survival, inefficient intestinal colonization and inadequate targeting. Inspired by the multi-level cooperative mechanism of defense protection–danger sensing–tissue repair observed in coral communities, we developed a core–shell bionic microcapsule reactor (MY-E@SS). Here we show that the multifunctional bionic shell enables safe delivery of engineered bacteria through the gastrointestinal tract. Upon reaching inflamed intestinal sites, these bacteria sense the pathological microenvironment and responsively release an anti-inflammatory peptide. In a male murine model of inflammatory bowel disease, this system exhibited excellent biocompatibility and pronounced therapeutic efficacy, restoring intestinal barrier integrity, attenuating systemic inflammation and oxidative stress, modulating respiratory metabolism, and reestablishing microbial homeostasis.

Probiotics have long been star ingredients in dairy foods, drinks, and supplements, promising to generate a better bacterial balance to our guts. On Apr. 26, the U.S. Food and Drug Administration (FDA) took a step toward formalizing the idea of adjusting gut-bacteria populations when it approved the first oral drug designed to treat the microbiome. Called SER-109, the pill is a cocktail of bacteria that can prevent recurring infections of C. difficile bacteria in people who have had previous episodes, and help them maintain healthy levels of gut bacteria. Keeping beneficial bacteria in proper balance could be an important way to keep disease-causing ones like C. difficile at bay.

The Prison Policy Initiative has compiled a comprehensive research collection examining how the criminal justice system affects public health outcomes and mortality rates. This curated resource aggregates existing research while highlighting the organization's original contributions to understanding this critical intersection. The initiative recognizes that incarceration and justice system involvement have significant health consequences extending beyond immediate physical safety concerns. By centralizing this body of knowledge, the Prison Policy Initiative provides researchers, policymakers, and practitioners with accessible evidence about health disparities linked to criminal justice involvement. The collection addresses the broader question of how systemic factors within prisons and the justice system impact population health, mortality patterns, and long-term health trajectories. This resource is part of the organization's larger research library, which covers diverse criminal justice topics. The focus on health implications represents growing recognition that effective criminal justice reform requires understanding and addressing the documented health consequences of incarceration, making this compilation valuable for evidence-based policy development and public health advocacy.

A recent study from Mass General Brigham reveals a significant gap between current cholesterol levels and newly released 2026 American guidelines. Nearly one-third of U.S. adults without heart disease and almost four-fifths of those with prior cardiovascular events have LDL cholesterol above recommended targets. Notably, approximately three-quarters of at-risk adults without heart disease receive no cholesterol-lowering medication despite eligibility. The 2026 guidelines introduced stricter LDL goals based on cardiovascular risk assessment, with lower targets for higher-risk patients. Researchers analyzed national data representing 178 million Americans, highlighting a substantial treatment gap that represents missed prevention opportunities for millions of individuals at risk for heart attacks and strokes.

Bioinks are developed using various polymers with crosslinkers. The crosslinkers play a crucial role in the formation of bioinks, which can be natural or synthetic (ionic, chemical, photo, etc.). However, extensive usage of crosslinkers limits the clinical application of bioinks due to compromising the ideal properties of bioinks, such as cytocompatibility, biodegradability, and biomechanical properties. Therefore, the potential solution to this problem is utilizing the click chemistry approach. The click chemistry strategy can achieve efficient bio-inks without compromising their intrinsic and optimal characteristics, as click reactions are rapid, spontaneous, and bioorthogonal, favoring the gelation time, rate of degradation, and cell viability.

Patient experience represents a fundamental dimension of healthcare quality that extends beyond clinical excellence and treatment accessibility. It encompasses how patients perceive and navigate their care journey, including their understanding of information, sense of being heard, continuity of support, and attention to practical, emotional, and social needs. This concept proves particularly critical in chronic disease management, which demands sustained follow-up and active patient participation. For healthcare providers, optimizing patient experience serves as a strategic lever to better understand individual needs, enhance care coordination, and foster patient engagement. Distinguishing patient experience from experiential knowledge—lived reality versus insights derived from it—enables organizations to capture authentic perspectives and implement meaningful improvements throughout care pathways.

France's healthcare system faces a critical sustainability challenge despite significant investment. With spending at 333 billion euros representing 11.4% of GDP and growing at 3.6% annually, the system struggles to convert financial resources into tangible health outcomes and patient experiences. Structural inefficiencies manifest through increasing care access tensions, fragmented care pathways, and professional burnout. Social security deficits reached 21.6 billion euros in 2025, with projections indicating potential healthcare insurance deficits of 41 billion euros by 2030 without major reforms. Rather than debating budgetary expansion versus rationing, France must adopt a Value-Based Healthcare approach, prioritizing the transformation of each euro spent into measurable health results and improved patient care delivery.

Un manque de coordination des soins ou de communication peut être à l'origine de toute une série de problèmes, comme par exemple des examens réalisés en double, ...

Le Français Withings frappe un grand coup outre-Atlantique, puisque la medtech fondée par Éric Carreel devient la seule entreprise européenne retenue par les autorités américaines pour le lancement d'un tout nouveau programme de santé.

Food is Medicine (FIM) initiatives offer a promising strategy to prevent and manage diet-related chronic diseases, including type 2 diabetes. These approaches connect people to nutritious foods that support the management of diet-related conditions. For state health departments working to increase enrollment and retention in the National Diabetes Prevention Program (National DPP) lifestyle change program, FIM initiatives can be a powerful and cost-effective complement to improve participant engagement and health outcomes.

Food insecurity affects over 47 million Americans and pervades every social work practice setting, from pediatric clinics to child welfare offices. Functioning as a critical social determinant of health, food insecurity compounds chronic disease, depression, and economic instability. Despite its pervasiveness, most social work curricula inadequately address food access, requiring practitioners to build expertise independently. This comprehensive guide equips social workers with validated screening tools, intervention models with proven outcomes, and policy advocacy strategies to address this systemic issue. The guide reframes food insecurity as a predictable consequence of structural inequity rather than individual failure. By emphasizing accurate screening, evidence-based program connections, and systemic policy change, social workers occupy a central role in shifting toward solutions that address the root causes of food access disparities.

The administration works to integrate substance use disorder and mental health with physical health care, to promote successful treatments, and to serve people ...

Optum, UnitedHealth Group's behavioral health division, implemented a documented cost-reduction strategy targeting applied behavior analysis therapy for autistic children enrolled in Medicaid plans. Internal documents revealed by ProPublica disclosed deliberate efforts to limit ABA access through network restrictions, provider terminations, and market-specific action plans that could eliminate up to 40% of in-network providers in certain states. Optum contested these findings, citing significant network expansion. The strategy reflects Medicaid managed care economics, where insurers receive fixed monthly capitation fees regardless of service utilization, creating financial incentives to reduce expensive treatments like intensive ABA therapy.

Digital health technologies have expanded rapidly through telemedicine, wearables, and AI, yet significant inequities persist for rural, elderly, and socioeconomically disadvantaged populations vulnerable to infrastructure disruptions. Current approaches prioritize technological innovation over trust, adaptation, and health literacy. This perspective advocates for symbiotic health ecosystems where clinicians, patients, caregivers, communities, and AI systems collaborate rather than deploying isolated AI tools. The authors propose that calibrated human-AI collaboration, supported by resilient, locally adaptive infrastructures including telemedicine, remote monitoring, backup energy systems, and community-supported models, can strengthen healthcare delivery in underserved and disrupted contexts. This framework emphasizes trustworthy, contextually appropriate solutions applicable beyond Nordic examples to diverse underserved populations globally.